Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Padagis US LLC recalls Trospium Chloride Extended-Release Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
Products
  • Trospium Chloride Extended-Release Capsules
Where it was sold

Nationwide in the USA

Nationwide

Units affected
7,032 bottles
About this recall
Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30